SOAT1 and neoplasm: In this case, JAK-STAT and Glutamatergic synapse pathways are previously verified cancer pathways [51, 52], where JAK-STAT signalling is a cornerstone to cancer progression, either as a tumour intrinsic driver of cancer growth/metastasis, or as a modulator of immune surveillance.